The DOI matches its Crossref record.
A Randomized Controlled Trial of Prednisone in Patients with Idiopathic Membranous Nephropathy
Abstract
We conducted a prospective randomized study in which patients with biopsy-confirmed idiopathic membranous nephropathy were assigned to receive either a six-month course of prednisone given on alternate days (45 mg per square meter of body-surface area; n = 81) or no specific treatment (n = 77). The mean duration of follow-up was 48 months. Patients in the prednisone group (median age, 46 years) entered with a mean disease duration of 15 months, a median creatinine clearance of 1.2 ml per second per 1.73 m2 (range, 0.25 to 2.6), and a median rate of urinary protein excretion of 6.8 g per day (0.3 to 26). The annual change in the corrected creatinine clearance at six months did not differ between the prednisone group and the control group (0.10 vs. 0.06 ml per second; P = 0.8), or at the last follow-up evaluation (-0.07 vs. -0.02 ml per second; P = 0.2; 95 percent confidence interval on the difference, -0.03 to 0.13). The proportion of patients with complete remission of proteinuria was also similar in the groups at 6 and 12 months and after a mean of 48 months. Outcomes were similar in the two groups with respect to progression to renal failure (3 vs. 4 patients), death (3 vs. 1 patient), complete remission of proteinuria at 36 months (16 vs. 19 patients), and a decline of 25 percent or more in the creatinine clearance at 60 months (32 vs. 25 percent of patients). A multivariate analysis, which adjusted for differences at entry in sex distribution, urinary protein excretion, and creatinine concentration, as well as other prognostic variables, failed to provide an explanation for the lack of effect of prednisone. We conclude that a six-month course of therapy in which prednisone is given on alternate days is of no benefit to patients with idiopathic membranous nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Faulds, D., Goa, K. L., & Benfield, P. (1993) · Drugs · doi:10.2165/00003495-199345060-00007 · Cited by 468
Faulds, D., Goa, K. L., & Benfield, P. (1993) · Drugs · doi:10.1007/bf03259110 · Cited by 436
Ponticelli, C., Zucchelli, P., Passerini, P., Cesana, B., Locatelli, F., Pasquali, S., Sasdelli, M., Redaelli, B., Grassi, C., Pozzi, C., et al. (1995) · Kidney International · doi:10.1038/ki.1995.453 · Cited by 407
Tacrolimus monotherapy in membranous nephropathy: A randomized controlled trial
Praga, M., For the GRUPO ESPAÑOL DE ESTUDIO DE LA NEFROPATÍA MEMBRANOSA (Members of the Group listed at the end of the paper), Barrio, V., Juárez, G. F., & Luño, J. (2007) · Kidney International · doi:10.1038/sj.ki.5002215 · Cited by 280
Idiopathic membranous nephropathy: Definition and relevance of a partial remission
Troyanov, S., Wall, C. A., Scholey, J. W., Miller, J. A., & Cattran, D. C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00873.x · Cited by 257
Self-citation
Metadata
- Authors
- Cattran, D. C., Delmore, T., Roscoe, J., Cole, E., Cardella, C., Charron, R., Ritchie, S., & the Toronto Glomerulonephritis Study Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1989-01-26
- Volume
- 320
- Issue
- 4
- Pages
- 210-215
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2020987938
- Cited by
- 232
- References
- 0
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Randomized Controlled Trial of Prednisone in Patients with Idiopathic Membranous Nephropathy. https://app.cochat.ai/papers/10.1056/nejm198901263200403
- The paper
- Cattran, D. C., Delmore, T., Roscoe, J., Cole, E., Cardella, C., Charron, R., Ritchie, S., & the Toronto Glomerulonephritis Study Group. (1989). A Randomized Controlled Trial of Prednisone in Patients with Idiopathic Membranous Nephropathy. New England Journal of Medicine. https://doi.org/10.1056/nejm198901263200403
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.